Table 3.

Unadjusted associations between Pregnancy complications and MA use

	All women (n=251)				Women with no other drug use (n=119)
	Any MA use during pregnancy n=144	No MA use during pregnancy n=107			Only MA during pregnancy n=60	No drug use during pregnancy n=59
Pregnancy Complications	n (percent)	n (percent)	OR (95%CI)	p-value	n (percent)	n (percent)	OR (95%CI)	p-value
Preterm delivery	18 (12.6)	13 (12.0)	1.05 (0.5–2.3)	1.00	8 (13)	3 (5)	2.8 (0.7–11.2)	0.2
Low birth weight	15 (10.7)	10 (9.4)	1.2 (0.5–2.7)	0.83	8 (13)	2 (3.4)	4.3 (0.9–21.2)	0.09
Chronic Hypertension	11 (7.7)	2 (1.9)	4.4 (0.9–20.2)	0.035	3 (4.9)	0 (0)	NA	0.24
Preeclampsia	10 (7.0)	4 (3.7)	1.94 (0.6–6.3)	0.28	4 (6.6)	2 (3.4)	2.0 (0.4–11.5)	0.68
Cesarean Delivery	46 (32.2)	15 (12.0)	2.9 (1.5–5.6)	0.0006	12 (19.7)	4 (6.8)	3.4 (1.0–11.1)	0.058
NICU Admission	10 (7.3)	10 (9.6)	0.74 (0.3–1.9)	0.63	4 (6.8)	2 (3.6)	1.9 (0.3–11.0)	0.68
Small for gestational age	15 (10.5)	15 (14.0)	0.72 (0.3–1.5)	0.43	8 (13)	6 (10.3)	1.3 (0.4–4.0)	0.78

NICU=newborn intensive care unit, OR=odds ratio, CI=confidence interval.

n and percentages may differ by column due to lack of data on outcome